Notch signaling in solid tumors
- PMID: 20816403
- DOI: 10.1016/S0070-2153(10)92013-9
Notch signaling in solid tumors
Abstract
In recent years a substantial body of evidence derived from not only preclinical but also clinical studies has accumulated in support of Notch signaling playing important oncogenic roles in several types of cancer. The finding that activating Notch mutations are frequently found in patients suffering from acute lymphoblastic leukemia is one of the best examples for a critical role of Notch signaling in cancer, a fact that motivated many researchers and clinicians to study the role of Notch also in solid tumors. Hence Notch signaling has gained increasing attention as a potential therapeutic target. In this book chapter we would like to discuss our current knowledge of Notch signaling within different types of solid cancers as well as advantages and disadvantages of potential new therapies that try to target the oncogenic properties of Notch signaling.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Multiple functions of Notch signaling in self-renewing organs and cancer.FEBS Lett. 2006 May 22;580(12):2860-8. doi: 10.1016/j.febslet.2006.03.024. Epub 2006 Mar 20. FEBS Lett. 2006. PMID: 16574107 Review.
-
Notch signaling: emerging molecular targets for cancer therapy.Biochem Pharmacol. 2010 Sep 1;80(5):690-701. doi: 10.1016/j.bcp.2010.03.026. Epub 2010 Mar 31. Biochem Pharmacol. 2010. PMID: 20361945 Review.
-
Exploitation of the Notch signaling pathway as a novel target for cancer therapy.Anticancer Res. 2008 Nov-Dec;28(6A):3621-30. Anticancer Res. 2008. PMID: 19189643 Review.
-
Interplay between Notch signaling and epigenetic silencers in cancer.Cancer Res. 2006 Sep 15;66(18):8931-4. doi: 10.1158/0008-5472.CAN-06-1858. Cancer Res. 2006. PMID: 16982729 Review.
-
Modulating Notch signaling by pathway-intrinsic and pathway-extrinsic mechanisms.Curr Opin Genet Dev. 2008 Oct;18(5):449-54. doi: 10.1016/j.gde.2008.07.013. Epub 2008 Sep 4. Curr Opin Genet Dev. 2008. PMID: 18722525 Review.
Cited by
-
Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition.Leukemia. 2024 Jul;38(7):1581-1591. doi: 10.1038/s41375-024-02292-w. Epub 2024 May 29. Leukemia. 2024. PMID: 38811818
-
Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance.Cell Mol Life Sci. 2023 Aug 19;80(9):263. doi: 10.1007/s00018-023-04907-4. Cell Mol Life Sci. 2023. PMID: 37598126 Free PMC article. Review.
-
The Therapeutic Landscape of Salivary Gland Malignancies-Where Are We Now?Int J Mol Sci. 2022 Nov 28;23(23):14891. doi: 10.3390/ijms232314891. Int J Mol Sci. 2022. PMID: 36499216 Free PMC article. Review.
-
The Role of Proprotein Convertases in Upper Airway Remodeling.Mol Cells. 2022 Jun 30;45(6):353-361. doi: 10.14348/molcells.2022.0019. Mol Cells. 2022. PMID: 35611689 Free PMC article. Review.
-
GIT1 protects against breast cancer growth through negative regulation of Notch.Nat Commun. 2022 Mar 22;13(1):1537. doi: 10.1038/s41467-022-28631-y. Nat Commun. 2022. PMID: 35318302 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
